Phosphodiesterase III inhibition promotes differentiation and survival of oligodendrocyte progenitors and enhances regeneration of ischemic white matter lesions in the adult mammalian brain. - Wikidata - awgldk - TriplyDB

Phosphodiesterase III inhibition promotes differentiation and survival of oligodendrocyte progenitors and enhances regeneration of ischemic white matter lesions in the adult mammalian brain.

Phosphodiesterase III inhibition promotes differentiation and survival of oligodendrocyte progenitors and enhances regeneration of ischemic white matter lesions in the adult mammalian brain.

http://www.wikidata.org/entity/Q34170865

about

The pathobiology of vascular dementia Olprinone attenuates the acute inflammatory response and apoptosis after spinal cord trauma in mice Cilostazol activates function of bone marrow-derived endothelial progenitor cell for re-endothelialization in a carotid balloon injury model Hemisphere Asymmetry of Response to Pharmacologic Treatment in an Alzheimer's Disease Mouse Model Pathophysiologic cascades in ischemic stroke Oligogenesis and oligodendrocyte progenitor maturation vary in different brain regions and partially correlate with local angiogenesis after ischemic stroke.Oligodendrocyte precursors induce early blood-brain barrier opening after white matter injury.Subcortical ischemic vascular disease: Roles of oligodendrocyte function in experimental models of subcortical white-matter injury.Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions An MRI-histological study of white matter in stroke-free SHRSP Electroacupuncture ameliorates memory impairments by enhancing oligodendrocyte regeneration in a mouse model of prolonged cerebral hypoperfusion Age-related decline in oligodendrogenesis retards white matter repair in mice.Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zone-derived progenitor cells in white matter diseases.Effects of Aging on Neural Stem/Progenitor Cells and Oligodendrocyte Precursor Cells After Focal Cerebral Ischemia in Spontaneously Hypertensive Rats Oxidative stress interferes with white matter renewal after prolonged cerebral hypoperfusion in mice.A Novel Three-Dimensional Culture System for Oligodendrocyte Precursor Cells.Long-term cilostazol treatment reduces gliovascular damage and memory impairment in a mouse model of chronic cerebral hypoperfusion.Adrenomedullin deficiency and aging exacerbate ischemic white matter injury after prolonged cerebral hypoperfusion in mice.Cilostazol attenuates kainic acid-induced hippocampal cell death.A-Kinase Anchor Protein 12 is Required for Oligodendrocyte Differentiation in Adult White Matter.Physical Exercise Improves Cognitive Function Together with Microglia Phenotype Modulation and Remyelination in Chronic Cerebral Hypoperfusion.Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke.Pericyte-derived bone morphogenetic protein 4 underlies white matter damage after chronic hypoperfusion.Quetiapine prevents oligodendrocyte and myelin loss and promotes maturation of oligodendrocyte progenitors in the hippocampus of global cerebral ischemia mice.Comparison of cognitive performance between two rat models of vascular dementia.

P2860

Q27006033-77932D19-8D73-4909-9587-2829263B3232 Q28475420-CDEF461A-1A14-4A7D-86C8-945F0B849DD7 Q28477044-1E44703E-9D66-4D99-AA7D-D9E08CA8DBEA Q28828290-D04C8E87-62CB-4749-86AC-0250D2D820C8 Q34282729-654AB984-A3A9-4992-9812-F46162043B40 Q35385916-5573E9B7-5096-496B-99C4-A2FBC7E5B5B0 Q36580349-9204BCD8-0E2D-4C0F-A4B8-62234137A283 Q36593234-6D29AFB2-1C46-4D20-BE27-DDD9E5550AC0 Q36799847-E8C4A0B2-613E-41FE-B646-89AB52C64E8F Q36839958-F97A4CEC-A134-4A51-8BF5-E153EC943CFF Q37044528-4064AC2A-3A08-4CC3-B0C1-50AAA07F0387 Q37282997-5CDFCE1B-6BC0-492A-8E1D-935F5DCA074F Q37414117-05A4DC00-EE12-4F85-9F1D-A4D88C14C1FA Q37664643-DCAA54E0-3261-4A53-9792-E2D1FDE19428 Q37701407-DD3CEBCE-09AE-415A-9ED4-27ACDD147CF7 Q38818268-4EF9D4E3-78D6-4796-B172-235B99E1CDCD Q41025659-82AB2026-0C14-4A0F-AFBE-486E5932A78C Q42181196-D18B798B-6AE6-45C2-AD26-9DE612AECAD8 Q47123849-A63E130C-A1F5-410A-AB8A-94774D577FCD Q47219063-52B5A173-C353-488D-9A10-85A6E0F5E0ED Q47222203-016537B8-A6B2-4DFB-8EDB-B11F67EE201A Q48068131-FABEAF77-CD4B-4E6B-A1A1-A7EF7C86B049 Q48194042-87F9B763-B0C9-4734-BC2E-3157DE750E71 Q48433788-94087CB2-F0C4-420E-BB09-A1594D85BC60 Q50697773-42A9820E-5D8F-4EC5-8DD9-FC26D8E68EDC

P2860

Phosphodiesterase III inhibition promotes differentiation and survival of oligodendrocyte progenitors and enhances regeneration of ischemic white matter lesions in the adult mammalian brain.

http://www.wikidata.org/entity/Q34170865

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Phosphodiesterase III inhibiti ...... in the adult mammalian brain.

@ast

Phosphodiesterase III inhibiti ...... in the adult mammalian brain.

@en

Phosphodiesterase III inhibiti ...... in the adult mammalian brain.

@nl

type

label

Phosphodiesterase III inhibiti ...... in the adult mammalian brain.

@ast

Phosphodiesterase III inhibiti ...... in the adult mammalian brain.

@en

Phosphodiesterase III inhibiti ...... in the adult mammalian brain.

@nl

prefLabel

Phosphodiesterase III inhibiti ...... in the adult mammalian brain.

@ast

Phosphodiesterase III inhibiti ...... in the adult mammalian brain.

@en

Phosphodiesterase III inhibiti ...... in the adult mammalian brain.

@nl

P1433

Q34170865-C40C2AD7-A00E-4AB2-8384-29FCC5A199F3

P1476

Q34170865-F778B2BE-19AC-4DC4-A4AA-6379F1976892

P2093

Q34170865-0214F19A-BB53-4995-8587-5E601B0442AB

Q34170865-27F448BE-3D50-41A1-B8A8-E0527567094B

Q34170865-29D78FFA-0583-4A8B-BDDC-2533D4E2EDB0

Q34170865-2B830844-BB43-4980-AE70-5D57D600B3D6

Q34170865-3D1AE634-F210-45C0-92EA-208141F83A29

Q34170865-473495A2-BCFF-48BB-9D07-AB314E571C2C

Q34170865-7ED2CEA3-F6D7-417F-B987-6405E6EA2C4D

Q34170865-A26C7B21-4A91-4C4B-BEEA-FC0EFD057602

P2860

Q34170865-08CF7724-536B-4AB9-82F2-7F6407B1DD63

Q34170865-0B2FA529-4143-4442-9C09-5601D106B01C

Q34170865-1CF609A2-4223-4172-8013-5AA70F207B1F

Q34170865-258299E0-1567-44D2-86B6-1ECB397C047C

Q34170865-26E76A58-35D0-4404-B845-6F3700527640

Q34170865-2CC3BA99-7D95-426E-894D-36FE87BCE677

Q34170865-30A7E82D-8D78-4A6F-AFC3-EBDA0C75AD27

Q34170865-31A56B17-DDF2-4283-8614-D3B912CC2465

Q34170865-322BEAF9-86FD-4268-AA92-C052AE2D3228

Q34170865-32354D4E-A5C9-4B0E-B9C7-4CDE527797C7

P304

Q34170865-DC4DF314-F80B-456B-9E9F-47A7719E4DD6

P31

Q34170865-B5563FBE-742A-4E09-BCF6-6FBC4102F3DD

P356

Q34170865-6AB5C981-1373-45FE-997F-8B0335ECD279

P433

Q34170865-8B1984AC-5277-4A14-A2AA-2AD610877C8B

P478

Q34170865-B8210012-5D13-45A6-AC4D-927F22CBC2EC

P50

Q34170865-B4C70B9D-530B-4244-A8A4-A089670BDDD1

P577

Q34170865-E56A20F5-4F97-4CA0-9744-E104A6AF7904

P5875

Q34170865-67ABD061-63DA-435A-92CB-5ECE5C6719E0

P698

Q34170865-C8D1D122-E35D-447B-A7A4-2C66C0006573

P921

Q34170865-437FD561-D76E-4D94-B90D-4F23FB833365

P932

Q34170865-B6F7F825-35CC-4DCB-BEA2-3CF62E0D8DC2

P356

P1433

Journal of Cerebral Blood Flow & Metabolism

P1476

Phosphodiesterase III inhibiti ...... in the adult mammalian brain.

@en

P2093

Hideki Mochizuki

http://www.w3.org/2001/XMLSchema#string

Hideki Shimura

http://www.w3.org/2001/XMLSchema#string

Hideo Mori

http://www.w3.org/2001/XMLSchema#string

Masafumi Onodera

http://www.w3.org/2001/XMLSchema#string

Nobukazu Miyamoto

http://www.w3.org/2001/XMLSchema#string

Ryota Tanaka

http://www.w3.org/2001/XMLSchema#string

Takao Urabe

http://www.w3.org/2001/XMLSchema#string

Terubumi Watanabe

http://www.w3.org/2001/XMLSchema#string

P2860

Cilostazol in secondary prevention of stroke: impact of the Cilostazol Stroke Prevention Study

Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells

FGF-2 converts mature oligodendrocytes to a novel phenotype.

Neuronal replacement from endogenous precursors in the adult brain after stroke

Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination.

Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.

Both oligodendrocytes and astrocytes develop from progenitors in the subventricular zone of postnatal rat forebrain.

Behavioral tests of hippocampal function: simple paradigms complex problems.

Endogenous progenitors remyelinate demyelinated axons in the adult CNS.

Cerebral blood flow in dementia.

P304

299-310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JCBFM.2009.210

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Nobutaka Hattori

P577

2009-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26892019

http://www.w3.org/2001/XMLSchema#string

P698

19826432

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte

P932

2949130

http://www.w3.org/2001/XMLSchema#string